Pliant Therapeutics (PLRX) EBT Margin (2020 - 2023)
Pliant Therapeutics (PLRX) reported EBT Margin of 16609.68% for Q2 2023, down 1601745.0% year-over-year from N/an in Q2 2022, and down 489.22% quarter-over-quarter from 2818.92% in Q1 2023.
Pliant Therapeutics (PLRX) EBT Margin (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has 4 years of EBT Margin data on file, last reported at 16609.68% in Q2 2023.
- EBT Margin for Q2 2023 came in at 16609.68%, down 1601745.0% year-over-year; the trailing twelve-month figure through Mar 2024 was 68847.98% (down 6748876.0% YoY), and the FY2023 annual result was 10211.14%, down 893782.0% from the prior year.
- EBT Margin eased to 16609.68% in Q2 2023 per PLRX's latest filing, from 2818.92% in the prior quarter.
- Over five years, EBT Margin peaked at 38.11% in Q1 2020 and troughed at 16609.68% in Q2 2023.
- A 4-year average of 2325.63% and a median of 1251.68% in 2021 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2023: EBT Margin soared 68396 bps in 2022, then tumbled 1601745 bps in 2023.
- A 4-year view of EBT Margin shows it stood at 426.14% in 2020, then tumbled by 188 bps to 1227.16% in 2021, then sank by 45 bps to 1784.22% in 2022, then sank by 831 bps to 16609.68% in 2023.
- Business Quant data shows PLRX's EBT Margin at 16609.68% in Q2 2023, 2818.92% in Q1 2023, and 1784.22% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -16,609.68% |
| Mar 31, 2023 | -2,818.92% |
| Dec 31, 2022 | -1,784.22% |
| Sep 30, 2022 | -2,065.79% |
| Jun 30, 2022 | -592.22% |
| Mar 31, 2022 | -2,249.80% |
| Dec 31, 2021 | -1,227.16% |
| Sep 30, 2021 | -1,679.81% |
| Jun 30, 2021 | -1,276.19% |
| Mar 31, 2021 | -1,051.33% |
| Dec 31, 2020 | -426.14% |
| Sep 30, 2020 | -343.46% |
| Jun 30, 2020 | -472.25% |
| Mar 31, 2020 | 38.11% |